DrugPatentWatch Database Preview

Alcon Company Profile

ALCON has fifty-one approved drugs.

There is one US patent protecting ALCON drugs. There is one tentative approval on ALCON drugs.

There are eighteen patent family members on ALCON drugs in sixteen countries and thirty-two supplementary protection certificates in eleven countries.

International Patents:	18
US Patents:	1
Tradenames:	45
Ingredients:	38
NDAs:	51
Patent Litigation for Alcon:	See patent lawsuits for Alcon
PTAB Cases with Alcon as patent owner:	See PTAB cases with Alcon as patent owner

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alcon Labs Inc	ALCAINE	proparacaine hydrochloride	SOLUTION/DROPS;OPHTHALMIC	080027-001	Approved Prior to Jan 1, 1982	AT	RX	No	No		➤ Sign Up				➤ Sign Up
Alcon	CETAPRED	prednisolone acetate; sulfacetamide sodium	OINTMENT;OPHTHALMIC	087771-001	Aug 6, 1993		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alcon Pharms Ltd	PREDNISOLONE SODIUM PHOSPHATE	prednisolone sodium phosphate	SOLUTION/DROPS;OPHTHALMIC	081044-001	Oct 24, 1991		DISCN	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008	5,578,578	➤ Sign Up
Alcon	PROFENAL	suprofen	SOLUTION/DROPS;OPHTHALMIC	019387-001	Dec 23, 1988	4,035,376	➤ Sign Up
Alcon	BSS PLUS	calcium chloride; dextrose; glutathione disulfide; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	018469-001	Approved Prior to Jan 1, 1982	4,550,022	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Ophthalmic Solution	0.03%	➤ Subscribe	2004-12-23
➤ Subscribe	Ophthalmic Solution	0.00%	➤ Subscribe	2008-11-28

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Canada	2431368	➤ Sign Up
World Intellectual Property Organization (WIPO)	0249614	➤ Sign Up
South Korea	100767159	➤ Sign Up
Country	Document Number	Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2014000088	Germany	➤ Sign Up	PRODUCT NAME: EZETIMIB ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON IN KOMBINATION MIT ATORVASTATIN ODER PHARMAZEUTISCH ANNEHMBARE SALZE DAVON, INSBESONDERE ATORVASTATIN ALS ATORVASTATINCALCIUMTRIHYDRAT; NAT. REGISTRATION NO/DATE: 90223.00.00 20141113; FIRST REGISTRATION: FRANKREICH CIS: 6 928 917 6 20140912
2012017	Lithuania	➤ Sign Up	PRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
C/GB12/047	United Kingdom	➤ Sign Up	PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.